The RNA 7SK Small Nuclear Pseudogene 119: A Potential Drug Target and Biomarker

Target Name: RN7SKP119

NCBI ID: G106481749

RN7SKP119

Other Name(s): RNA, 7SK small nuclear pseudogene 119 | RN7SK pseudogene 119

The RNA 7SK Small Nuclear Pseudogene 119: A Potential Drug Target and Biomarker

The RNA 7SK small nuclear pseudogene 119 (RNA7SK119) is a non-coding RNA molecule that has been identified in various organisms, including humans. It is characterized by its unique structure, which consists of 7 exons and a single intron. RNA7SK119 has been implicated in various cellular processes, including gene regulation, DNA replication, and repair, cell signaling, and cell survival.

Drug Target Potential

RNA7SK119 has been identified as a potential drug target due to its unique structure and various functions. One of the key reasons for its potential as a drug target is its expression level, which has been shown to be highly expressed in various tissues and organs, including brain, heart, and cancer. Additionally, RNA7SK119 has been shown to play a role in various cellular processes that are crucial for human health, such as cell proliferation, apoptosis, and autophagy.

RNA7SK119 has also been shown to interact with various signaling molecules, including TGF-β, NF-kappa-B, and SMAP. These interactions may indicate a potential role for RNA7SK119 in the regulation of cellular processes that are important for human health and disease. Therefore, targeting RNA7SK119 with small molecules or other therapeutic agents may be an effective way to treat various diseases, including cancer.

Biomarker Potential

In addition to its potential as a drug target, RNA7SK119 also has the potential as a biomarker for various diseases. The expression level of RNA7SK119 has been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Additionally, RNA7SK119 has been shown to be involved in the regulation of cellular processes that are important for disease development and progression.

RNA7SK119 may be a useful biomarker for various diseases due to its expression level and involvement in cellular processes that are important for disease progression. Therefore, measuring the expression level of RNA7SK119 may be an effective way to diagnose and monitor diseases, including cancer.

Conclusion

In conclusion, RNA7SK small nuclear pseudogene 119 is a non-coding RNA molecule that has been identified in various organisms, including humans. It has been shown to play a role in various cellular processes, including gene regulation, DNA replication, and repair, cell signaling, and cell survival. RNA7SK119 has also been identified as a potential drug target due to its unique structure and various functions. Additionally, RNA7SK119 has the potential as a biomarker for various diseases due to its expression level and involvement in cellular processes that are important for disease progression. Therefore, targeting RNA7SK119 with small molecules or other therapeutic agents may be an effective way to treat various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

Protein Name: RN7SK Pseudogene 119

The "RN7SKP119 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SKP119 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets